BFC Planning’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BFC Planning's PPH Position: Q3 2026 in Review
BFC Planning increased its VanEck Pharmaceutical ETF (PPH) stake by 1.6% in Q3 2026, buying an estimated $2.01K and bringing the position to 1,157 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #1140.
BFC Planning first reported a position in PPH in Q3 2024 and has held it in 9 quarters since. 127 funds tracked by Wall St. Rank hold PPH as of Q3 2026.
- BFC Planning held 1,157 shares of VanEck Pharmaceutical ETF worth $127K as of Q3 2026.
- BFC Planning bought 18 VanEck Pharmaceutical ETF shares in Q3 2026, an estimated $2.01K.
- VanEck Pharmaceutical ETF made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1140 holding.
- BFC Planning first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and has held it in 9 quarters since.
- 127 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.